- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Del buys Villa Sistemi Medicali
X-ray manufacturer Del Global Technologies has purchased a 19% stake in Milan-based Villa Sistemi Medicali, and has obtained an exclusive option to increase its ownership interest to 80% of the company’s capital stock. Villa Sistemi produces
X-ray manufacturer Del Global Technologies has purchased a 19% stake in Milan-based Villa Sistemi Medicali, and has obtained an exclusive option to increase its ownership interest to 80% of the companys capital stock. Villa Sistemi produces radiographic/fluoroscopic technology, including portable and dental imaging systems. It has annual sales of approximately $20 million.
The move is part of Valhalla, NY-based Dels efforts to extend its reach as a supplier of medical imaging equipment worldwide. Del has been pursuing potential acquisitions, both in the U.S. and internationally, as the company seeks to expand (SCAN 2/17/99). The firms last purchase was in 1998, when it bought the x-ray assets of Acoma Medical Imaging of Wheeling, IL, for $1.4 million over three years (SCAN 12/16/98). That deal brought Del into the R/F market for the first time by giving it access to a cost-effective system manufactured by Acoma.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
